Brian brings a wealth of experiences in strategy, business development, M&A and marketing. Since joining West-Ward/Hikma in 2009, he has been instrumental in the growth of our Orals business in the US.
Brian was appointed President of West-Ward Pharmaceuticals in 2015 with responsibilities for two of Hikma’s facilities, supply chain, business development, and product selection. Brian originally joined West-Ward in 2009 to develop a strategy function for West-Ward to accelerate future growth for the business. Brian was later promoted to new roles including VP Corporate Development and SVP & General Manager. During his time with West-Ward, Brian has led many strategic initiatives including the acquisitions and integrations of Baxter’s Multi-Source Injectables business and Boehringer Ingelheim’s Roxane Laboratories. Brian has developed many strategic partnerships for West-Ward to supplement the company’s internal pipeline, bring in new technologies, and reach new markets.
Before coming to West-Ward, Brian worked for L.E.K. Consulting as a management consultant in their Boston office. He led engagements for clients in a wide variety of areas including growth strategy, merger evaluation and integration, new product launches, and strategic alliances. Earlier in his career Brian spent a number of years in marketing, market research, and sales roles within the pharmaceutical and consumer packaged goods industries.
Brian holds a Bachelor’s Degree in Business Administration from Boston University Questrom School of Management and an MBA from the University of Chicago Booth School of Business with concentrations in strategic management, finance, and marketing.